From: Molecular modeling and lead design of substituted zanamivir derivatives as potent anti-influenza drugs
Data set
Average
Max.
Min.
Std dev
Sum
Training
−2.4963
−1.3032
−4.5955
0.6975
−39.9406
Test
−2.5855
−1.7396
−4.5396
0.8352
−20.6838